These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

501 related items for PubMed ID: 8514571

  • 1. Extra-label drug use--pharmaceutical industry view.
    Welser JR.
    J Am Vet Med Assoc; 1993 May 15; 202(10):1635-42;discussion 1654-8. PubMed ID: 8514571
    [No Abstract] [Full Text] [Related]

  • 2. An overview of current programs on drug development and regulation for small ruminants--pharmaceutical industry perspective.
    Terry M.
    Vet Hum Toxicol; 1993 May 15; 35 Suppl 2():12-3. PubMed ID: 8236759
    [No Abstract] [Full Text] [Related]

  • 3. Professional responsibilities.
    Jenkins WL.
    J Am Vet Med Assoc; 1993 May 15; 202(10):1742-3. PubMed ID: 8514601
    [No Abstract] [Full Text] [Related]

  • 4. Extra-label drug use--veterinary practitioner views: food animals.
    Johnson DE.
    J Am Vet Med Assoc; 1993 May 15; 202(10):1645-7;discussion 1654-8. PubMed ID: 8514573
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The learned intermediary doctrine: past, present and future.
    Alsobrook HB.
    Leg Med; 1994 May 15; ():269-80. PubMed ID: 7830482
    [No Abstract] [Full Text] [Related]

  • 9. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products.
    Fed Regist; 1978 Sep 29; 43(190 Pt 2):45013-89. PubMed ID: 10316700
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Implications for the FDA/Center for Veterinary Medicine (CVM).
    Geyer RE.
    J Am Vet Med Assoc; 1993 May 15; 202(10):1718-23. PubMed ID: 8514592
    [No Abstract] [Full Text] [Related]

  • 14. Extra-label use policy of the Canadian Bureau of Veterinary Drugs.
    Ritter L, Alexander I.
    J Am Vet Med Assoc; 1993 May 15; 202(10):1623-6;discussion 1626-31. PubMed ID: 8514569
    [No Abstract] [Full Text] [Related]

  • 15. AHI perspectives: flexible drug labeling and its impact on the drug development process. Liability issues.
    Thomas JW.
    J Am Vet Med Assoc; 1995 Oct 01; 207(7):899-900; discussion 902-4. PubMed ID: 7559021
    [No Abstract] [Full Text] [Related]

  • 16. Illegal importation of medicines.
    Cooper P.
    Vet Rec; 1999 Jan 02; 144(1):28. PubMed ID: 10028575
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The responsibility of FDA to the livestock industry and the consumer. VI. Product stability and labeling for animal drugs and other feed additives.
    Knight WM, Gable DA, Golden RG.
    J Anim Sci; 1973 Jul 02; 37(1):223-5. PubMed ID: 4720864
    [No Abstract] [Full Text] [Related]

  • 20. FDA's regulation of prescription drug labeling: a role for implied preemption.
    Kendrick LC.
    Food Drug Law J; 2007 Jul 02; 62(1):227-47. PubMed ID: 17444031
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.